H.B. 386 Summary

• Establishes a state drug take-back program requiring drug manufacturers to collect and dispose of prescription and nonprescription drugs to prevent misuse and environmental contamination.

• Covered manufacturers must participate in an approved drug take-back program by July 1, 2022, or establish their own program; manufacturers becoming covered after July 1, 2021 have six months to comply.

• Creates collection system requirements including secure receptacles at retail pharmacies, hospitals, clinics, and law enforcement agencies, with mail-back and periodic collection events for underserved areas.

• Requires covered drugs to be disposed at permitted hazardous waste facilities or approved alternative disposal methods; prohibits charging consumers or point-of-collection fees for participation.

• Grants the Department of Public Safety authority to approve programs, conduct audits, assess penalties up to $2,000 per violation, and collect fees not exceeding 10% of annual program expenditures; takes effect July 1, 2021.